Announcements Trials
Browse Landscape

Phase

Phase 2 65Phase 3 21Phase 1 9Phase 2/3 8Phase 1/2 5Phase NA 3Phase 4 2Phase EARLY_PHASE1 1

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Non-Small-Cell Lung 9Head and Neck Neoplasms 4Small Cell Lung Carcinoma 3Lymphoma, Extranodal NK-T-Cell 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Uterine Cervical Neoplasms 1Squamous Non-small-cell Lung Cancer 1Squamous Cell Carcinoma of Head and Neck 1Non-Small Cell Lung Cancer Metastatic 1Neuroendocrine Tumors 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Melanoma 1Medulloblastoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Mantle-Cell 1Lymphohistiocytosis, Hemophagocytic 1Lung Neoplasms 1Locally Advanced Malignant Neoplasm 1Intracranial Germ Cell Tumors 1Carcinoma, Squamous Cell 1Cancer Therapy-related Cardiovascular Toxicity 1Anemia 1Adenocarcinoma of Lung 1

Interventions

Cisplatin 2tislelizumab 1Radiotherapy 1Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Esophageal Squamous Cell Carcinoma × Cisplatin × Clear all
NCT06388135 2024-04-29

Serplulimab Combined With Nab-paclitaxel and Cisplatin in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma

Xijing Hospital

Phase 4 Not yet recruiting
80 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05603065 2023-06-29

TINES

First Affiliated Hospital Xi'an Jiaotong University

Phase 4 Unknown
32 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡